+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07621055

Real-World Study of Volta Medical AI Software Use During Catheter Ablation for Atrial Fibrillation and Arrhythmias

Led by Volta Medical · Updated on 2026-06-22

150

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and performance of the latest Volta Medical AI software called Volta AF-Xplorer II during catheter ablation procedures for atrial fibrillation and related arrhythmias. This observational study, named VOLTAIRE-AF, observes how the AI software performs in real-world clinical practice without changing usual treatment workflows. The study follows patients for up to 24 months to assess both acute and long-term outcomes. Participants undergo catheter ablation where the Volta AF-Xplorer II software is used during the mapping phase to identify patient-specific areas of interest in the heart. The actual ablation method is chosen by the treating doctor based on standard care. After the procedure, participants receive follow-up visits scheduled quarterly within the first 9 months and then annually up to 24 months to monitor their heart condition and treatment effects. During the study, patients are monitored for adverse events, recurrence of arrhythmias, and symptoms related to heart failure and atrial fibrillation using standard scores NYHA and EHRA. Quality of life is assessed before the procedure and at least annually using the EQ-5D-3L questionnaire. The main outcomes include freedom from arrhythmia recurrence, serious incidents related to the AI software or ablation, and progression of symptoms and hospitalizations over the 24-month follow-up period.

CONDITIONS

Brief Title

VOLta Medical AI-software in REal-World During AF Ablation

Research Team

P

Paola MILPIED

C

Cecile BIELMANN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here